The Technical Analyst
Aethlon Medical Inc [AEMD]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Aethlon Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.05% $1.430
America/New_York / 16 apr 2024 @ 12:45
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3.75 mill |
| EPS: | -5.01 |
| P/E: | -0.290 |
| Earnings Date: | Jun 26, 2024 |
| SharesOutstanding: | 2.62 mill |
| Avg Daily Volume: | 0.0080 mill |
| RATING 2024-04-16 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.290 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.290 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.330 - 1.530 ( +/- 6.99%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-29 | Gikakis Nicolas | Sell | 1 954 | Common Stock |
| 2024-03-29 | Broenniman Edward G | Sell | 1 163 | Common Stock |
| 2024-03-29 | Shah Chetan | Sell | 1 163 | Common Stock |
| 2023-12-29 | Gikakis Nicolas | Sell | 1 954 | Common Stock |
| 2023-12-29 | Broenniman Edward G | Sell | 1 163 | Common Stock |
| INSIDER POWER |
|---|
| 70.09 |
| Last 96 transactions |
| Buy: 2 698 058 | Sell: 210 105 |
Forecast:
14:25 - $1.414
Live Trading Signals (every 1 min)
Forecast
1: 12:55 - $1.430
Forecast 2: 13:45 - $1.414
Forecast 3: 14:25 - $1.414
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.430 (-2.05% ) |
| Volume | 0.0037 mill |
| Avg. Vol. | 0.0080 mill |
| % of Avg. Vol | 46.66 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For AEMD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
AEMD
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Latest Press Releases
2024-02-21 08:01:00 - Press Release
Aethlon Medical Enters Into Materials Transfer Agreement For Santersus Ag's Nucleocapture And Hemonucleocapture Devices
Aethlon medical will perform pre-clinical studies to explore potential synergies with its first-in-class hemopurifier® blood filtration system san diego , feb. 21, 2024 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it entered into a materials transfer agreement (mta) with santersus ag, a zurich-london based, privately held therapeutic medical device company, for santersus' nucleocapture and hemonucleocapture devices. under the terms of the mta, santersus will supply aethlon with nucleocapture and hemonucleocapture devices, designed to remove neutrophil extracellular traps (nets), which are toxic to tissues and organs and are implicated in the pathophysiology of cancer, sepsis, autoimmune diseases, such as lupus, and ischemia reperfusion injury in organ transplantation.
2024-02-14 16:15:00 - Press Release
Aethlon Medical Announces Fiscal Third Quarter Financial Results And Provides Corporate Update
Conference call to be held today at 4:30 p.m. et san diego , feb. 14, 2024 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended december 31, 2023 and provided an update on recent developments.
2024-02-07 08:00:00 - Press Release
Aethlon Medical To Release Fiscal Third Quarter Financial Results And Host Conference Call On February 14, 2024
San diego , feb. 7, 2024 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended december 31, 2023, at 4:15 p.m. et on wednesday, february 14, 2024.
2023-11-14 16:15:00 - Press Release
Aethlon Medical Announces Fiscal Second Quarter Financial Results And Provides Corporate Update
Conference call to be held today at 4:30 p.m. et san diego , nov. 14, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal second quarter ended september 30, 2023 and provided an update on recent developments.
2023-11-13 08:01:00 - Press Release
Aethlon Medical Announces Appointment Of James B. Frakes, M.b.a.
San diego , nov. 13, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that james b. frakes, m.b.a.
Latest News
2024-02-14 21:17:06 - Seeking Alpha
Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript
2023-11-14 22:01:06 - Seeking Alpha
Aethlon Medical, Inc. (AEMD) Q2 2024 Earnings Call Transcript
Aethlon Medical, Inc. (NASDAQ:AEMD ) Q2 2024 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Michael Miller - Rx Communications, IR Jim Frakes - Interim CEO and CFO Steven LaRosa - CMO Guy Cipriani - COO Conference Call Participants Marla Marin - Zacks Thomas McGovern - Maxim Group Vernon Bernardino - H.C. Wainwright Operator Good day, and welcome to the Aethlon Medical Second Quarter Fiscal 2024 Earnings and Corporate Update Call.
2023-11-06 08:01:00 - PRNewsWire
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
SAN DIEGO , Nov. 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral infections and for use in organ transplantation, today announced that it will issue financial results for its second quarter ended September 30, 2023, at 4:15 p.m. ET on Tuesday, November 14, 2023.
2023-08-30 08:01:00 - PRNewsWire
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
SAN DIEGO , Aug. 30, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that Steven LaRosa, M.D., Chief Medical Officer, and James Frakes, Chief Financial Officer, will present a company overview on Tuesday, September 12 at 4:30 PM EST, during the H.C.
2023-08-10 21:17:06 - Seeking Alpha
Aethlon Medical, Inc. (AEMD) Q1 2024 Earnings Call Transcript
Aethlon Medical, Inc. (NASDAQ:AEMD ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jim Frakes – Chief Financial Officer Charles J. Fisher, Jr. – Chief Executive Officer Steven LaRosa – Chief Medical Officer Conference Call Participants Marla Marin – Zacks Vernon Bernardino – H.C.
2023-06-22 08:01:00 - PRNewsWire
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
SAN DIEGO , June 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it will issue financial results for its fourth quarter ended March 31, 2023, at 4:15 p.m. EST on Wednesday, June 28, 2023.
2023-06-14 08:01:00 - PRNewsWire
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
SAN DIEGO , June 14, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that Charles J. Fisher, Jr. M.D.
2023-06-01 15:51:00 - PRNewsWire
Aethlon Medical to Present at the 13th Annual LD Micro Invitational
SAN DIEGO , June 1, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that Guy Cipriani, Senior Vice President and Chief Business Officer, and James Frakes, Chief Financial Officer, will present a company overview at the 13th Annual LD Micro Invitational on Wednesday, June 7, 2023, at 1:30 PM PT. Management will also be participating in one-on-one meetings with investors at this conference being held June 6-8, 2023, in Los Angeles, California.
2023-04-24 13:15:26 - PennyStocks
5 Hot Penny Stocks To Watch With The Stock Market Down This Week
Hot penny stocks to watch this week. This is a significant week for earnings, and mega-cap tech names will headline what's sure to be a volatile week. Next week, the action continues with the upcoming Fed meeting and another rate hike decision.
2023-04-21 06:00:00 - PennyStocks
Essential Penny Stock Trading Tools: Maximizing Efficiency
Use these tips for trading penny stocks efficiently The post Essential Penny Stock Trading Tools: Maximizing Efficiency appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.